newsfilter
← Latest News
PR Newswire·

Edgewise Therapeutics Reports Second Quarter 2026 Financial Results

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases, today reported...